
Key facts: BioVie Inc. reports $6.1M Q4 loss; faces operational issues

I'm PortAI, I can summarize articles.
BioVie Inc. posted a net loss of $6.1 million for Q4 2025, a $1.0 million drop from Q4 2024, mainly due to reduced research and admin costs.1BioVie faces operational and financial issues, including clinical programs and legal matters, along with recent actions like a reverse stock split and plans for a spin-off.2
- BioVie Inc. posted a net loss of $6.1 million for Q4 2025, a $1.0 million drop from Q4 2024, mainly due to reduced research and admin costs.1
- BioVie faces operational and financial issues, including clinical programs and legal matters, along with recent actions like a reverse stock split and plans for a spin-off.2
